Kiniksa Pharmaceuticals

News

Roche adds to pipeline with Poseida, Kiniksa deals

Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases.

Partner Content

Partner Content

New speaker session with Kiniksa Pharmaceuticals at Pre-fill...

Session with Kiniksa Pharmaceuticals at PFS East Coast

News

MSD ordered to pull injectable Keytruda from sale in Europe

MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Kiniksa Pharmaceuticals

Editor's Picks